Drug response studies using biomimetic models
Journal: Drug Resistance Updates
Sábado 20 de Febrero del 2021 a Domingo 21 de Febrero del 2021
Grupo de Oncología Matemática

The poor response of glioblastoma to current treatment protocols is a consequence of its intrinsic drug resistance. Resistance to chemotherapy is primarily associated with considerable cellular heterogeneity, and plasticity of glioblastoma cells, alterations in gene expression, presence of specific tumor microenvironment conditions and blood-brain barrier. In an attempt to successfully overcome chemoresistance and better understand the biological behavior of glioblastoma, numerous tri-dimensional (3D) biomimetic models were developed in the past decade. These novel advanced models are able to better recapitulate the spatial organization of glioblastoma in a real time, therefore providing more realistic and reliable evidence to the response of glioblastoma to therapy. Moreover, these models enable the fine-tuning of different tumor microenvironment conditions and facilitate studies on the effects of the tumor microenvironment on glioblastoma chemoresistance. 

Researchers from Serbia, Zaragoza and MOLAB have reviewed the state of the art in that field in a paper recently published in the journal Drug Resistance Updates, a high impact factor journal (11.0) according to the Web of Science. 

For more details:



(Image from freepik: <a href="https://www.freepik.es/fotos/medico">Foto de Médico creado por freepik - www.freepik.es</a>)